Explore the full archive of TIME, a century of journalism, insight, and perspective, with AI that helps you research, connect ...
Suzetrigine is a prescription pill taken every 12 hours after a larger starter dose. The US Food and Drug Administration signed off Thursday on the first new type of pain reliever to be approved in ...
Halneuron, a NaV 1.7 sodium channel inhibitor, is being tested for chemotherapy-induced neuropathic pain, offering a potential opioid alternative. Previous trials showed Halneuron significantly ...
(CNN) -- The US Food and Drug Administration signed off Thursday on the first new type of pain reliever to be approved in more than two decades. (CNN) — The US Food and Drug Administration signed off ...
(CNN) — The US Food and Drug Administration signed off Thursday on the first new type of pain reliever to be approved in more than two decades. The drug, suzetrigine, is a 50-milligram prescription ...
Journavx (suzetrigine), a non-opioid pill for moderate-to-severe acute pain, has just received FDA approval. It’s the first drug in a new family of medicines that block pain signals before they reach ...